- Home
- RIGL vs NFBK Comparison
RIGL vs NFBK Comparison
Compare RIGL & NFBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RIGL
- NFBK
- Stock Information
- Founded
- RIGL 1996
- NFBK 1887
- Country
- RIGL United States
- NFBK United States
- Employees
- RIGL N/A
- NFBK N/A
- Industry
- RIGL Biotechnology: Pharmaceutical Preparations
- NFBK Major Banks
- Sector
- RIGL Health Care
- NFBK Finance
- Exchange
- RIGL Nasdaq
- NFBK Nasdaq
- Market Cap
- RIGL 537.6M
- NFBK 454.5M
- IPO Year
- RIGL 2000
- NFBK 2007
- Fundamental
- Price
- RIGL $41.64
- NFBK $10.31
- Analyst Decision
- RIGL Buy
- NFBK Hold
- Analyst Count
- RIGL 6
- NFBK 3
- Target Price
- RIGL $39.83
- NFBK $12.67
- AVG Volume (30 Days)
- RIGL 652.5K
- NFBK 187.0K
- Earning Date
- RIGL 11-04-2025
- NFBK 10-22-2025
- Dividend Yield
- RIGL N/A
- NFBK 4.91%
- EPS Growth
- RIGL 2698.26
- NFBK 51.92
- EPS
- RIGL 6.20
- NFBK 0.97
- Revenue
- RIGL $282,076,000.00
- NFBK $141,983,000.00
- Revenue This Year
- RIGL $59.93
- NFBK $9.42
- Revenue Next Year
- RIGL N/A
- NFBK $7.14
- P/E Ratio
- RIGL $6.77
- NFBK $10.89
- Revenue Growth
- RIGL 79.13
- NFBK 13.99
- 52 Week Low
- RIGL $14.63
- NFBK $9.40
- 52 Week High
- RIGL $43.72
- NFBK $14.39
- Technical
- Relative Strength Index (RSI)
- RIGL 69.25
- NFBK 40.66
- Support Level
- RIGL $34.00
- NFBK $9.91
- Resistance Level
- RIGL $39.56
- NFBK $10.62
- Average True Range (ATR)
- RIGL 2.36
- NFBK 0.26
- MACD
- RIGL 1.09
- NFBK 0.05
- Stochastic Oscillator
- RIGL 91.70
- NFBK 45.27
About RIGL Rigel Pharmaceuticals Inc.
Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, the only oral spleen tyrosine kinase (SYK) inhibitor, Fostamatinib, R289, R552, R835, DS-3032, THF-beta Inhibitors, and AZD0449- Inhaled JAK Inhibitor.
About NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.